FIGURE 1.
Adult patients with inflammatory bowel disease without current/past anticoagulation use between 2020 and 2021, divided into groups based on principal discharge diagnosis of COVID‐19.
| Characteristic | No COVID‐19 | Uncomplicated COVID‐19 | Complicated COVID‐19 | p |
|---|---|---|---|---|
| Mean age | 51.64 | 60.13 | 63.78 | 0.001 |
| Age category (years) | 0.001 | |||
| 18–45 | 39.20% | 17.30% | 8.90% | |
| 45–65 | 32.00% | 41.30% | 37.30% | |
| > 65 | 28.80% | 41.40% | 53.80% | |
| Gender | 0.012 | |||
| Male | 43.00% | 44.80% | 49.60% | |
| Female | 57.00% | 55.20% | 50.40% | |
| Race | 0.877 | |||
| White | 74.70% | 75.40% | 76.60% | |
| Black | 11.80% | 11.50% | 9.70% | |
| Hispanics | 7.00% | 6.90% | 7.60% | |
| Others | 6.50% | 6.20% | 6.00% | |
| Insurance status | 0.001 | |||
| Medicare | 38.30% | 48.90% | 59.80% | |
| Medicaid | 17.40% | 10.40% | 6.80% | |
| Private insurance | 40.30% | 38.60% | 32.60% | |
| Self‐pay | 4.00% | 2.10% | 0.80% | |
| Elixhauser comorbidity index | 0.001 | |||
| 0 | 12.80% | 5% | 1% | |
| 1 | 18.10% | 15.40% | 4.70% | |
| 2 | 18.70% | 20.20% | 10.20% | |
| 3 or more | 50.40% | 59.00% | 83.70% | |
| Median household income in patient's ZIP code (quartile) | 0.001 | |||
| 1st (0–25) | 24.90% | 26.70% | 28.90% | |
| 2nd (26–50) | 25.70% | 27.30% | 26.00% | |
| 3rd (51–75) | 25.00% | 26.30% | 27.60% | |
| 4th (76–100) | 24.40% | 19.70% | 17.50% | |
| Hospital bed size | 0.001 | |||
| Small | 22.10% | 28.00% | 24.70% | |
| Medium | 26.80% | 27.30% | 33.60% | |
| Large | 51.10% | 44.70% | 41.70% | |
| Hospital teaching status | 0.001 | |||
| Non‐teaching | 23.20% | 31.10% | 31.20% | |
| Teaching | 76.80% | 68.90% | 68.80% | |
| Hospital location | 0.001 | |||
| Rural | 6.90% | 11.90% | 12.90% | |
| Urban | 93.10% | 88.10% | 87.10% | |
| Anemia | 36.10% | 20.10% | 33.60% | 0.001 |
| DM | 16.80% | 27.50% | 33.60% | 0.001 |
| HTN | 41.20% | 55.90% | 68.00% | 0.001 |
| Smoking | 38.60% | 36.70% | 32.80% | 0.016 |
| Obesity | 14.40% | 24.60% | 37.00% | 0.001 |
| CKD/ESRD | 11.90% | 14.40% | 17.30% | 0.001 |
| CHF | 8.00% | 8.10% | 18.90% | 0.001 |
| Dyslipidemia | 23.30% | 36.40% | 38.60% | 0.001 |
| Malnutrition | 13.40% | 5.90% | 13.90% | 0.001 |
| COPD | 10.60% | 15.00% | 22.60% | 0.001 |
| Cancer | 10.60% | 40.20% | 60.40% | 0.001 |
| Chronic lung disease | 19.50% | 27.20% | 32.60% | 0.001 |
| Cirrhosis | 3.30% | 2.30% | 3.20% | 0.065 |
| Steroid use | 6.00% | 5.50% | 6.60% | 0.605 |
| Contraceptive use | 0.03% | 0.00% | 0.00% | 0.745 |
| Vasculitides | 2.40% | 2.20% | 2.60% | 0.985 |
| Carotid atherosclerotic disease | 0.60% | 0.20% | 1.10% | 0.03 |
| Renal atherosclerotic disease | 0.10% | 0.10% | 0.00% | 0.812 |
| HIV | 0.70% | 0.50% | 0.30% | 0.436 |
| Peripheral artery disease | 2.60% | 2.50% | 4.20% | 0.124 |
| Coronary artery disease | 10.10% | 15.60% | 16.80% | 0.001 |